SPRINGfondet
VC Fund
Oslo, Norway
Springfondet is a seed capital fund located at Oslo Innovation Center in Oslo, Norway. The fund invests in technology startups across a broad range of industries.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries SPRINGfondet invests in
Stages SPRINGfondet invests in
Countries SPRINGfondet invests in
Investment Focus
Industry
- Software 2 (67%)
- Database 1 (33%)
- Hardware 1 (33%)
- Security 1 (33%)
- Analytics 1 (33%)
Stage
- Funding Round 2 (67%)
- Seed 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Promon is an app security firm specializing in In-App Protection / Application Shielding. Our solutions focus largely on runtime protection (malware protection), code integrity protection (obfuscation), and securing sensitive app data and assets. The company works across a range of industries with a variety of global Tier 1 clients, countingcustomers in industries such as finance, health, and the public sector. Promon’s technology is research-based and originates from the internationally recognized research environments at SINTEF and the University of Oslo. Promon’s patented deep protection technology Promon SHIELD™ has protected apps and applications used by more than 100 Mill users since 2009. Promon AS is a Norwegian limited company registered in 2006, with offices in Asia, the US, Germany, the UK, and India. The head office is in Oslo, Norway. | Aug 25, 2013 | ||
| Swarm64 (swarm64.com) provides accelerators for relational databases that enable real-time analytics of high velocity data. Swarm64’s team is world-class in delivering FPGA acceleration and real-time database design. Founded in 2013, Swarm64 is backed by leading Norwegian and German venture investors. Swarm64 is a Norwegian company with operationsin Berlin, Germany. | $614K / Seed / Aug 25, 2013 | ||
| Kappa Bioscience is the pioneer in development and production of the only synthetic and biologically active all-trans menaquinone-7 (vitamin K2 MK-7), marketed under the K2VITAL® brand name. Kappa’s innovation of MK-7 synthesis marks the commercial milestone where this fat-soluble vitamin can begin to attain widespread consumer adoption. Effectivesynthesis production drives scalability, price reduction and a secure supply chain - with unmatched ingredient purity and documentation. Combined with other Kappa innovations such as the patented DELTA® microencapsulation process, which provides K2 stability in mineral formulations, K2VITAL® offers brands and manufacturers a path to broader market segments. Kappa Ingredients GmbH, a wholly owned division of Kappa Bioscience, manages global sales of the K2VITAL® and other product lines directly and through a network of global distributors.Kappa Ingredients GmbH, a wholly owned division of Kappa Bioscience, manages global sales of the K2VITAL® and other product lines - Ingredients and services related to Bones, Joints and Cardiovascular Health - directly and through a network of global distributors. Main products are Vitamin K2 - K2VITAL®, Calcified Atlantic Seaweed®, The Bone Health Triangle®. | Jan 01, 2009 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does SPRINGfondet invest in?
SPRINGfondet invests primarily in Software, Database and Hardware startups, most often at Funding Round and Seed stage. Most of the 3 investments tracked by Shizune back companies in Norway. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did SPRINGfondet last invest?
The most recent investment recorded for SPRINGfondet closed in Aug 2013. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
